These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
86 related articles for article (PubMed ID: 9675654)
1. Antiblastic drug targeting to hepatocellular carcinoma cells: a potential therapeutic improvement? Merle P; Trepo C Ital J Gastroenterol Hepatol; 1998 Apr; 30(2):178-80. PubMed ID: 9675654 [No Abstract] [Full Text] [Related]
2. Conjugation of 5-fluoro-2'-deoxyuridine with lactosaminated poly-l-lysine to reduce extrahepatic toxicity in the treatment of hepatocarcinomas. Di Stefano G; Busi C; Derenzini M; Trerè D; Fiume L Ital J Gastroenterol Hepatol; 1998 Apr; 30(2):173-7. PubMed ID: 9675653 [TBL] [Abstract][Full Text] [Related]
3. A role for hepatic-directed chemotherapy in colorectal liver metastases. Ensminger WD J Clin Oncol; 2005 Aug; 23(22):4815-7. PubMed ID: 16009957 [No Abstract] [Full Text] [Related]
4. Receptor-mediated protection of normal hepatocytes during chemotherapy for hepatocellular carcinoma. Keegan-Rogers V; Wu CH; Wu GY Targeted Diagn Ther; 1991; 4():105-25. PubMed ID: 1665717 [No Abstract] [Full Text] [Related]
5. Bioluminescent imaging of hepatocellular carcinoma in live mice. Wang Y; Sun Z; Peng J; Zhan L Biotechnol Lett; 2007 Nov; 29(11):1665-70. PubMed ID: 17609854 [TBL] [Abstract][Full Text] [Related]
6. [Successful treatment of combined intraarterial (5-fluorouracil and adriamycin and cisplatin) infusion chemotherapy for advanced hepatocellular carcinoma with multiple intrahepatic metastases and/or portal vein thrombosis--two case reports]. Kato H; Nagano H; Ota H; Nakamura M; Wada H; Yoshioka S; Noda T; Bazarragchaa D; Marubashi S; Miyamoto A; Takeda Y; Umeshita K; Dono K; Murakami T; Nakamura H; Monden M Gan To Kagaku Ryoho; 2005 Oct; 32(11):1842-5. PubMed ID: 16315958 [TBL] [Abstract][Full Text] [Related]
7. Hepatic arterial infusion chemotherapy for metastases from colorectal cancer: is it really the end of an era? D'Angelica M; Fong Y; DeMatteo RP; Jarnagin WR J Clin Oncol; 2008 Jun; 26(16):2788-9; author reply 2789-90. PubMed ID: 18509192 [No Abstract] [Full Text] [Related]
9. Molecular prediction of response to 5-fluorouracil and interferon-alpha combination chemotherapy in advanced hepatocellular carcinoma. Kurokawa Y; Matoba R; Nagano H; Sakon M; Takemasa I; Nakamori S; Dono K; Umeshita K; Ueno N; Ishii S; Kato K; Monden M Clin Cancer Res; 2004 Sep; 10(18 Pt 1):6029-38. PubMed ID: 15447987 [TBL] [Abstract][Full Text] [Related]
10. Effect of pravastatin on survival in patients with advanced hepatocellular carcinoma. A randomized controlled trial. Kawata S; Yamasaki E; Nagase T; Inui Y; Ito N; Matsuda Y; Inada M; Tamura S; Noda S; Imai Y; Matsuzawa Y Br J Cancer; 2001 Apr; 84(7):886-91. PubMed ID: 11286466 [TBL] [Abstract][Full Text] [Related]
11. Delivery of high levels of anti-proliferative nucleoside triphosphates to CYP3A-expressing cells as a potential treatment for hepatocellular carcinoma. MacKenna DA; Montag A; Boyer SH; Linemeyer DL; Erion MD Cancer Chemother Pharmacol; 2009 Oct; 64(5):981-91. PubMed ID: 19283354 [TBL] [Abstract][Full Text] [Related]
12. Pilot study of combination chemotherapy of S-1, a novel oral DPD inhibitor, and interferon-alpha for advanced hepatocellular carcinoma with extrahepatic metastasis. Nakamura M; Nagano H; Marubashi S; Miyamoto A; Takeda Y; Kobayashi S; Wada H; Noda T; Dono K; Umeshita K; Monden M Cancer; 2008 Apr; 112(8):1765-71. PubMed ID: 18327806 [TBL] [Abstract][Full Text] [Related]
13. A combination therapy with transarterial chemo-lipiodolization and systemic chemo-infusion for large extensive hepatocellular carcinoma invading portal vein in comparison with conservative management. Jang JW; Bae SH; Choi JY; Oh HJ; Kim MS; Lee SY; Kim CW; Chang UI; Nam SW; Cha SB; Lee YJ; Chun HJ; Choi BG; Byun JY; Yoon SK Cancer Chemother Pharmacol; 2007 Jan; 59(1):9-15. PubMed ID: 16614848 [TBL] [Abstract][Full Text] [Related]
14. Coupling of 5-fluoro 2'-deoxyuridine to lactosaminated poly-l-lysine: an approach to a regional, non-invasive chemotherapy of liver micrometastases. Di Stefano G; Busi C; Camerino A; Derenzini M; Trerè D; Fiume L Biochem Pharmacol; 2001 Feb; 61(4):459-65. PubMed ID: 11226380 [TBL] [Abstract][Full Text] [Related]
15. [Chemotherapy for hepatocellular carcinoma]. Okusaka T; Ueno H; Ikeda M Gan To Kagaku Ryoho; 2004 Dec; 31(13):2122-8. PubMed ID: 15628756 [TBL] [Abstract][Full Text] [Related]
16. Androgen receptor and hepatocarcinogenesis: what do we learn from HCC mouse models? Zender L; Kubicka S Gastroenterology; 2008 Sep; 135(3):738-40. PubMed ID: 18692055 [No Abstract] [Full Text] [Related]
18. Can colorectal cancer patients with thymidylate synthase-overexpressing liver metastases have an overall survival advantage with hepatic arterial infusion alone? Alimonti A; Ferretti G; Di Cosimo S; Cognetti F; Vecchione A J Clin Oncol; 2003 Sep; 21(18):3543-4; author reply 3544-5. PubMed ID: 12972537 [No Abstract] [Full Text] [Related]
19. [Selective chemotherapy of hepatocellular carcinomas]. Keppler D; Pausch J; Gerok W Verh Dtsch Ges Inn Med; 1978; (84):606-10. PubMed ID: 217196 [No Abstract] [Full Text] [Related]
20. A phase II study of tegafur plus uracil or tegafur alone for the treatment of advanced hepatocellular carcinoma. Zavaglia C; Prisco C; Pinzello G Eur J Gastroenterol Hepatol; 2008 Jan; 20(1):87-8. PubMed ID: 18090998 [No Abstract] [Full Text] [Related] [Next] [New Search]